• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖和糖尿病相关的胰腺癌:一种针对其的替代方法。

Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.

机构信息

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA.

Sanguine Diagnostics and Therapeutics, University of Nebraska Medical Center, Omaha, NE, USA.

出版信息

J Exp Clin Cancer Res. 2018 Dec 19;37(1):319. doi: 10.1186/s13046-018-0963-4.

DOI:10.1186/s13046-018-0963-4
PMID:30567565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6299603/
Abstract

BACKGROUND

Pancreatic cancer (PC) is among foremost causes of cancer related deaths worldwide due to generic symptoms, lack of effective screening strategies and resistance to chemo- and radiotherapies. The risk factors associated with PC include several metabolic disorders such as obesity, insulin resistance and type 2 diabetes mellitus (T2DM). Studies have shown that obesity and T2DM are associated with PC pathogenesis; however, their role in PC initiation and development remains obscure.

MAIN BODY

Several biochemical and physiological factors associated with obesity and/or T2DM including adipokines, inflammatory mediators, and altered microbiome are involved in PC progression and metastasis albeit by different molecular mechanisms. Deep understanding of these factors and causal relationship between factors and altered signaling pathways will facilitate deconvolution of disease complexity as well as lead to development of novel therapies. In the present review, we focuses on the interplay between adipocytokines, gut microbiota, adrenomedullin, hyaluronan, vanin and matrix metalloproteinase affected by metabolic alteration and pancreatic tumor progression.

CONCLUSIONS

Metabolic diseases, such as obesity and T2DM, contribute PC development through altered metabolic pathways. Delineating key players in oncogenic development in pancreas due to metabolic disorder could be a beneficial strategy to combat cancers associated with metabolic diseases in particular, PC.

摘要

背景

胰腺癌(PC)是全球首要的癌症致死原因之一,其病因主要包括普遍存在的非特异性症状、缺乏有效的筛查策略,以及对化疗和放疗的耐药性。与 PC 相关的风险因素包括多种代谢紊乱,如肥胖、胰岛素抵抗和 2 型糖尿病(T2DM)。研究表明,肥胖和 T2DM 与 PC 的发病机制有关;然而,它们在 PC 的起始和发展中的作用仍不清楚。

主要内容

与肥胖和/或 T2DM 相关的多种生化和生理因素,包括脂肪因子、炎症介质和改变的微生物组,参与了 PC 的进展和转移,尽管其作用机制不同。深入了解这些因素及其与改变的信号通路之间的因果关系,将有助于解析疾病的复杂性,并为开发新的治疗方法提供依据。在本综述中,我们重点讨论了代谢改变和胰腺肿瘤进展中受影响的脂肪细胞因子、肠道微生物群、肾上腺髓质素、透明质酸、Vanin 和基质金属蛋白酶之间的相互作用。

结论

代谢疾病,如肥胖和 T2DM,通过改变代谢途径促进 PC 的发展。阐明代谢紊乱导致胰腺中致癌发展的关键因素,可能是对抗与代谢疾病相关的癌症(特别是 PC)的一种有益策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/0129829b754e/13046_2018_963_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/719c39567e51/13046_2018_963_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/bbf2184b551a/13046_2018_963_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/0129829b754e/13046_2018_963_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/719c39567e51/13046_2018_963_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/bbf2184b551a/13046_2018_963_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bec7/6299603/0129829b754e/13046_2018_963_Fig3_HTML.jpg

相似文献

1
Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.肥胖和糖尿病相关的胰腺癌:一种针对其的替代方法。
J Exp Clin Cancer Res. 2018 Dec 19;37(1):319. doi: 10.1186/s13046-018-0963-4.
2
The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.肥胖和糖尿病对胰腺癌的影响:分子机制和临床观点。
J Cell Mol Med. 2020 Jul;24(14):7706-7716. doi: 10.1111/jcmm.15413. Epub 2020 May 26.
3
Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.通过因果推理和中介分析来破译胰腺癌、糖尿病亚型和肥胖症/BMI 之间的复杂相互作用。
Gut. 2021 Feb;70(2):319-329. doi: 10.1136/gutjnl-2019-319990. Epub 2020 May 14.
4
The complexities of obesity and diabetes with the development and progression of pancreatic cancer.肥胖症和糖尿病与胰腺癌发生发展的复杂性。
Biochim Biophys Acta. 2011 Apr;1815(2):135-46. doi: 10.1016/j.bbcan.2010.11.003. Epub 2010 Dec 1.
5
Obesity and cancer pathogenesis.肥胖与癌症发病机制。
Ann N Y Acad Sci. 2014 Apr;1311:57-76. doi: 10.1111/nyas.12416.
6
The Role of Type 2 Diabetes in Pancreatic Cancer.2型糖尿病在胰腺癌中的作用。
Cureus. 2022 Jun 24;14(6):e26288. doi: 10.7759/cureus.26288. eCollection 2022 Jun.
7
Diabetes and pancreatic cancer.糖尿病与胰腺癌。
Mol Carcinog. 2012 Jan;51(1):64-74. doi: 10.1002/mc.20771.
8
Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.2型糖尿病及其与胰腺癌发生风险的关联:综述
Korean J Gastroenterol. 2016 Apr 25;67(4):168-77. doi: 10.4166/kjg.2016.67.4.168.
9
Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.炎症因子在胰腺癌发生中的作用及抗炎药物的预防作用。
Semin Immunopathol. 2013 Mar;35(2):203-27. doi: 10.1007/s00281-012-0340-x. Epub 2012 Sep 7.
10
New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts.胰腺癌的新策略:新兴的流行病学和治疗概念。
Clin Cancer Res. 2010 Sep 1;16(17):4313-8. doi: 10.1158/1078-0432.CCR-09-1942. Epub 2010 Jul 20.

引用本文的文献

1
The Oncogenic Burden of Obesity: Mechanistic Links Between Adiposity and Gastrointestinal Cancers-A Comprehensive Narrative Review.肥胖的致癌负担:肥胖与胃肠道癌症之间的机制联系——一篇全面的叙述性综述
Biomedicines. 2025 Jun 26;13(7):1571. doi: 10.3390/biomedicines13071571.
2
Integrated multi-omics profiling to establish an IGFBP-based prognostic score for pancreatic ductal adenocarcinoma: unraveling prognostic biomarkers, immune microenvironment crosstalk, and therapeutic implications.整合多组学分析以建立基于胰岛素样生长因子结合蛋白的胰腺导管腺癌预后评分:揭示预后生物标志物、免疫微环境相互作用及治疗意义
Front Immunol. 2025 May 15;16:1600527. doi: 10.3389/fimmu.2025.1600527. eCollection 2025.
3

本文引用的文献

1
Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.胰腺导管腺癌中的促纤维增生反应:对病理功能和治疗潜力的见解
Genes Cancer. 2018 Mar;9(3-4):78-86. doi: 10.18632/genesandcancer.171.
2
Pancreatic Cancer Following Incident Diabetes in African Americans and Latinos: The Multiethnic Cohort.非裔美国人和拉丁裔人群中确诊糖尿病后的胰腺癌:多民族队列研究。
J Natl Cancer Inst. 2019 Jan 1;111(1):27-33. doi: 10.1093/jnci/djy090.
3
Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1.
Mechanisms underlying obesity-malignancy connection: a systematic narrative review.
肥胖与恶性肿瘤关联的潜在机制:一项系统性叙述性综述
J Physiol Biochem. 2025 May 23. doi: 10.1007/s13105-025-01084-9.
4
Visualization of the Relationship Between Hyaluronic Acid and Wound Healing: A Bibliometric Analysis.透明质酸与伤口愈合关系的可视化:一项文献计量分析。
Skin Res Technol. 2025 Feb-May;31(2-5):e70164. doi: 10.1111/srt.70164.
5
Association of overweight/obesity and digestive system cancers: A meta-analysis and trial sequential analysis of prospective cohort studies.超重/肥胖与消化系统癌症的关联:一项前瞻性队列研究的荟萃分析和试验序贯分析
PLoS One. 2025 Apr 1;20(4):e0318256. doi: 10.1371/journal.pone.0318256. eCollection 2025.
6
Formin protein DAAM1 positively regulates PD-L1 expression via mediating the JAK1/STAT1 axis in pancreatic cancer.formin蛋白DAAM1通过介导胰腺癌中的JAK1/STAT1轴正向调节PD-L1的表达。
Cancer Cell Int. 2025 Jan 29;25(1):28. doi: 10.1186/s12935-024-03631-8.
7
Integrating New Approach Methodologies to Address Environmental Pancreatic Toxicity and Metabolic Disorders.整合新方法学以解决环境性胰腺毒性和代谢紊乱问题。
Biology (Basel). 2025 Jan 17;14(1):85. doi: 10.3390/biology14010085.
8
High Intelectin-1 Expression Associated with Aggressive Tumor Behavior and Worse Survival in Rectal Cancer.高整合素-1表达与直肠癌侵袭性肿瘤行为及较差生存率相关。
Onco Targets Ther. 2025 Jan 13;18:15-26. doi: 10.2147/OTT.S488608. eCollection 2025.
9
Emerging mechanisms and promising approaches in pancreatic cancer metabolism.胰腺癌代谢中的新兴机制与前景广阔的方法
Cell Death Dis. 2024 Aug 1;15(8):553. doi: 10.1038/s41419-024-06930-0.
10
Microbiota and metabolite alterations in pancreatic head and body/tail cancer patients.胰腺头和体/尾癌患者的微生物群和代谢物改变。
Cancer Sci. 2024 Aug;115(8):2738-2750. doi: 10.1111/cas.16238. Epub 2024 Jun 18.
香烟烟雾通过 PAF1 诱导胰腺癌干细胞特征
Gastroenterology. 2018 Sep;155(3):892-908.e6. doi: 10.1053/j.gastro.2018.05.041. Epub 2018 Jun 2.
4
Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years.晚期胰腺癌:一项超过三十年临床试验的荟萃分析。
Oncotarget. 2018 Apr 10;9(27):19396-19405. doi: 10.18632/oncotarget.25036.
5
Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer.瘦素-Notch轴削弱5-氟尿嘧啶对胰腺癌的作用。
Oncotarget. 2018 Apr 6;9(26):18239-18253. doi: 10.18632/oncotarget.24435.
6
Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response.肠道微生物群通过调节免疫反应促进小鼠肿瘤生长。
Gastroenterology. 2018 Jul;155(1):33-37.e6. doi: 10.1053/j.gastro.2018.04.001. Epub 2018 Apr 7.
7
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.胰腺癌微生物组通过诱导先天和适应性免疫抑制促进肿瘤发生。
Cancer Discov. 2018 Apr;8(4):403-416. doi: 10.1158/2159-8290.CD-17-1134. Epub 2018 Mar 22.
8
Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice.吉西他滨化疗对胰腺癌异种移植小鼠肠道微生物群的影响。
Cancer Chemother Pharmacol. 2018 Apr;81(4):773-782. doi: 10.1007/s00280-018-3549-0. Epub 2018 Feb 22.
9
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
10
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.Halo202:PEGPH20 联合 Nab-紫杉醇/吉西他滨与 Nab-紫杉醇/吉西他滨治疗未经治疗的转移性胰腺导管腺癌患者的随机 II 期研究。
J Clin Oncol. 2018 Feb 1;36(4):359-366. doi: 10.1200/JCO.2017.74.9564. Epub 2017 Dec 12.